Journals / MN Kardiyoloji / 2006 / Cilt: 13 - Sayı: 6

Electrocardiographic changes due to citalopram intoxication in a patient with WPW syndrome

WPW sendromlu bir hastada citalopram intoksikasyonuna bağlı EKG değişiklikleri

Pages
373–376
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We also showed that NaHCO3 can be used for also patients with WPW Syndrome for resolving electrocardiographic changes and decreasing the risk of arrhythmia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In childhood depression is seen mostly in adolescence, and can lead to suicide.
📊
Key Findings & Data:Here, a 15 year old patient was presented for taking overdose of citalopram which was prescribed for the depression, and the changes in the electrocardiography were evaluated.
💡
Conclusion & Impact:We also showed that NaHCO3 can be used for also patients with WPW Syndrome for resolving electrocardiographic changes and decreasing the risk of arrhythmia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ergen · İlaç toksisitesi · Elektrokardiyografi

Abstract

In childhood depression is seen mostly in adolescence, and can lead to suicide. The suicide cases generally are in the form of drug intoxication. Here, a 15 year old patient was presented for taking overdose of citalopram which was prescribed for the depression, and the changes in the electrocardiography were evaluated. With this case report the effects seen in the intoxication of serotonin reuptake inhibitors were also overviewed. We also showed that NaHCO3 can be used for also patients with WPW Syndrome for resolving electrocardiographic changes and decreasing the risk of arrhythmia.

Özet

Çocukluk yaş grubunda depresyon daha çok adelosan dönemde görülür ve intihara neden olabilir. Genellikle depresyon sonucunda görülen intihar vakaları ilaç intoksikasyonu şeklinde kendini gösterir. Burada 15 yaşındaki kız hasta depresyon nedeniyle reçete edilen citalopram'ın yüksek doz alımı sonucunda intoksikasyon nedeniyle sunulmuş, citalopram'a bağlı ortaya çıkan EKG değişiklikleri değerlendirilmiştir. Bu vaka ile WPW Sendromu'nda da citalopram'a bağlı EKG değişikliklerinin ve aritmi sıklığının azaltılması amacıyla NaHCO3'ün kullanılabileceği gösterilmiş, serotonin geri alım inhibitörü ilaç intoksikasyonuna bağlı olarak görülen bulgular da gözden geçirilmiştir.

🔖

Cite This Article

ÇAĞDAŞ, D. N., PAÇ, A. (2006). Electrocardiographic changes due to citalopram intoxication in a patient with WPW syndrome. MN Kardiyoloji, Cilt: 13 - Sayı: 6, 373–376. https://ajindex.com/articles/297532

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Rao U, Ryan ND, Birmaher B, et al. Unipolar depression in adolescents: clinical outcome in adulthood. J Am Acad Child Adolesc Psychiatry 1995; 34:566-78.
  2. Kovacs M, Feinberg TL, Crouse-Novak MA. Depressive disorders in childhood: II. A longitudinal study of the risk for a subsequent major depression. Arch Gen Psychiatry 1984; 41:643-9.
  3. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshelman S, Wittchen H, Kendler KS: Lifetime and 12 month prevalence of DSM-3R psychiatric disorders in the united states. Archives of General Psychiatry 1994; 51:8-19.
  4. Pataki CS, Carlson GA. Childhood and adolescent depression: a review. Harv Rev Psychiatry 1995; 3:140-51.
  5. Fleming JE, Offord DR, Boyle MH. Prevalence of childhood and adolescent depression in the community. Ontario Child Health Study. Br J Psychiatry 1989; 155:647-54.
  6. March J, Silva S, Petrycki S, et al; Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitive behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial; JAMA 2004; 292:807-20.
  7. Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry 1998; 15(59 Suppl):42-8.
  8. Catalano G, Catalano M, Epstein M, Tsambiras PE. QTc interval prolongation associated with citalopram overdose: a case report and literature review. Clin Neuropharmacol 2001; 24:158-62.
  9. Grundemar L, Wohlfart B, Lagerstedt C, et al. Symptoms and signs of severe citalopram overdose [letter]. Lancet 1997; 349:1602. Ostrom M, Eriksson A, Thorson J, Spigset O. Fatal overdose with citalopram. Lancet 1996; 348:339-40.
  10. Tan JY, Levin GM. Citalopram in the treatment of depression and other potential uses in psychiatry. Pharmacotherapy 1999; 19:675-89.
  11. Worm K, Dragsholt C, Simonsen K, et al. Citalopram concentrations in samples from autopsies and living persons. Int J Legal Med 1998; 111:188-90.
  12. Personne M, Sjoberg G, Persson H. Citalopram overdose: review of cases treated in Swedish hospitals. J Toxicol Clin Toxicol 1997; 35:237-40.
  13. Personne M, Persson H, Sjöberg G. Citalopram toxicity. Lancet 1997; 350(9076):518-9.
  14. Zehnder M, Hohnloser S, Just H. QT-interval prolonging drugs: mechanism and clinical relevance of their arrhythmogenic hazards. Cardiovasc Drugs Ther 1991; 5: 515-30.
  15. Boeck V, Fredricson Overö K, Svendsen O. Studies on acute toxicity and drug levels of citalopram in the dog. Acta Pharmacol Toxicol 1982; 50: 160-74.
  16. Engebretsen KM, Harris CR, Wood JE. Cardio